Amit Sachdev, EVP Chief Patient & Ext Af Officer at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 8,466 shares at $420.24 ($3.6M) on 2024-02-12, disclosed to the SEC on 2024-02-13.
Scheduled sale ($3.6M) by EVP Chief Patient & Ext Af Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $422.74 | 2,022 | $855K | 24.0% |
| 2 | $420.24 | 3,222 | $1.4M | 38.0% |
| 3 | $420.24 | 3,222 | $1.4M | 38.0% |
| Total | $420.84 avg | 8,466 | $3.6M | 100% |
| Filing → |
| VRTX | SELL | 2024-05-17 | $14K | — | Filing → |
| VRTX | SELL | 2024-02-27 | $2.6M | — | Filing → |
| VRTX | SELL | 2024-02-23 | $2.7M | — | Filing → |